Intech Investment Management LLC increased its holdings in DocGo Inc. (NASDAQ:DCGO – Free Report) by 76.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,834 shares of the company’s stock after purchasing an additional 14,247 shares during the period. Intech Investment Management LLC’s holdings in DocGo were worth $139,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its holdings in DocGo by 151.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock valued at $365,000 after buying an additional 66,097 shares during the period. Matrix Asset Advisors Inc. NY acquired a new stake in shares of DocGo in the fourth quarter worth approximately $424,000. Rhumbline Advisers increased its position in DocGo by 4.5% during the fourth quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock worth $605,000 after purchasing an additional 6,204 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in DocGo by 37.5% during the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock worth $5,647,000 after purchasing an additional 363,391 shares during the period. Finally, WCM Investment Management LLC boosted its holdings in shares of DocGo by 64.2% in the 4th quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after purchasing an additional 1,687,100 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have recently commented on DCGO. Stifel Nicolaus dropped their price objective on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a report on Friday, February 28th. Deutsche Bank Aktiengesellschaft downgraded DocGo from a “buy” rating to a “hold” rating and cut their price objective for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, Needham & Company LLC decreased their target price on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $4.89.
DocGo Stock Performance
DCGO stock opened at $2.73 on Friday. The firm has a market cap of $278.41 million, a P/E ratio of 9.75, a price-to-earnings-growth ratio of 14.16 and a beta of 1.08. DocGo Inc. has a 1 year low of $2.63 and a 1 year high of $5.68. The stock has a 50-day simple moving average of $4.06 and a 200-day simple moving average of $3.92.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Read More
- Five stocks we like better than DocGo
- EV Stocks and How to Profit from Them
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Top 3 Beverage Stocks Pouring Out Profits
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.